Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma

Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma

Show other versions (1)

<h4>Purpose</h4> To detect early response to sunitinib treatment in metastatic clear cell renal cancer (mRCC) using multiparametric MRI. <h4>Method</h4> Participants with mRCC undergoing pre-surgical sunitinib therapy in the prospective NeoSun clinical trial (EudraCtNo: 2005-...

Full description

Bibliographic Details
Main Authors: Stephan Ursprung, Andrew N. Priest, Fulvio Zaccagna, Wendi Qian, Andrea Machin, Grant D. Stewart, Anne Y. Warren, Timothy Eisen, Sarah J. Welsh, Ferdia A. Gallagher, Tristan Barrett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547646/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547646/?tool=EBI

Similar Items